We are live on ! Find out more
GKIM

GW&K Investment Management Portfolio holdings

AUM $12.8B
1-Year Est. Return 48.82%
This Fund
S&P 500
This Quarter Est. Return
+8.94%
1 Year Est. Return
+48.82%
3 Year Est. Return
+110.09%
5 Year Est. Return
+134.03%
10 Year Est. Return
+612.52%
AUM
$7.49B
AUM Growth
+$381M
Cap. Flow
-$168M
Cap. Flow %
-2.25%
Top 10 Hldgs %
11.97%
Holding
386
New
15
Increased
64
Reduced
279
Closed
9

Sector Composition

Rank Sector Weight
1 Industrials 17.04%
2 Technology 15.1%
3 Healthcare 14.17%
4 Financials 13.6%
5 Consumer Discretionary 13.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIK
376
DELISTED
Michaels Stores, Inc
MIK
$1K ﹤0.01%
80
-355
-82% -$2.98K
AMRX icon
377
Amneal Pharmaceuticals
AMRX
$6.89B
– –
-387
Closed -$1K
COHR icon
378
Coherent
COHR
$57.9B
– –
-2,937
Closed -$103K
LEN icon
379
Lennar Class A
LEN
$19.8B
$0 ﹤0.01%
7
– –
TUP
380
DELISTED
Tupperware Brands Corporation
TUP
– –
-45
Closed -$1K
ABMD
381
DELISTED
Abiomed Inc
ABMD
– –
-25
Closed -$4K
SNP
382
DELISTED
CHINA PETROLEUM & CHEMICAL CORPORATION ADS (REP 100 ORDINARY H SHARES)
SNP
– –
-114,252
Closed -$6.71M
MDP
383
DELISTED
Meredith Corporation
MDP
– –
-139
Closed -$5K
CBM
384
DELISTED
Cambrex Corporation
CBM
– –
-455,763
Closed -$27.1M
DOVA
385
DELISTED
Dova Pharmaceuticals, Inc. Common Stock
DOVA
– –
-330,621
Closed -$9.24M
MDSO
386
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-204
Closed -$19K

Similar funds

GW&K Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, GW&K Investment Management held 386 positions worth $7.49B, up 5.4% from $7.11B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GW&K Investment Management's Q4 2019 filing shows 15 new, 64 increased, 279 reduced and 9 closed positions. Its largest new stake was Veracyte: 1,020,082 shares worth $28.5M. The largest sale was Cambrex Corporation, an estimated $27.1M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.

  • GW&K Investment Management's largest Q4 2019 buy was Veracyte: 1,020,082 shares worth $28.5M.
  • GW&K Investment Management added most to Ollie's Bargain Outlet in Q4 2019, an estimated $23.3M increase.
  • GW&K Investment Management's biggest Q4 2019 reduction was TSMC, cutting an estimated $25.2M.
  • GW&K Investment Management fully exited Cambrex Corporation in Q4 2019, selling an estimated $27.1M.
  • GW&K Investment Management's ten largest holdings make up 12% of its $7.49B portfolio in Q4 2019.
  • GW&K Investment Management opened 15 new positions and closed 9 in Q4 2019.
  • GW&K Investment Management's portfolio value rose 5.4% quarter-over-quarter to $7.49B.

Based on GW&K Investment Management's 13F filing for Q4 2019, filed 10 Feb 2020.